Journal article
Effect of Glucose-Insulin-Potassium Infusion on Mortality in Patients With Acute ST-Segment Elevation Myocardial Infarction: The CREATE-ECLA Randomized Controlled Trial
Abstract
CONTEXT: Glucose-insulin-potassium (GIK) infusion is a widely applicable, low-cost therapy that has been postulated to improve mortality in patients with acute ST-segment elevation myocardial infarction (STEMI). Given the potential global importance of GIK infusion, a large, adequately powered randomized trial is required to determine the effect of GIK on mortality in patients with STEMI.
OBJECTIVE: To determine the effect of high-dose GIK …
Authors
Mehta SR; Yusuf S; Díaz R; Zhu J; Pais P; Xavier D; Paolasso E; Ahmed R; Xie C; Kazmi K
Journal
JAMA, Vol. 293, No. 4, pp. 437–446
Publisher
American Medical Association (AMA)
Publication Date
January 26, 2005
DOI
10.1001/jama.293.4.437
ISSN
0098-7484